Skip to content

The value of HPV integration in the management of cervical lesions in pregnant women

The value of HPV integration in the management of cervical lesions in pregnant women: an observational cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096815
Enrollment
Unknown
Registered
2025-02-07
Start date
2025-02-14
Completion date
Unknown
Last updated
2025-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

precancerous lesion of the uterine cervix

Interventions

Observation group:None

Sponsors

Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant patients aged 20 to 45 years old; 2. The patients have been diagnosed with ASC-US?ASC-H?CIN?AGC and or HPV 16/18 positive, who need colposcopy for cervical tissue biopsy; 3. The subjects voluntarily joined this study, signed an informed consent form, had good compliance, and cooperated with follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients who have been previously diagnosed with cervical HSIL and have undergone standardized surgical treatment; 2. History of malignant tumors in the reproductive system; 3. Patients who are unwilling to undergo follow-up 6 months after parturition; 4. Refusal to sign informed consent form.

Design outcomes

Primary

MeasureTime frame
Rates of cervical intraepithelial neoplasia 3 (CIN3) or more severe lesions in patients;Rate of regression of cervical lesions in patients;

Countries

China

Contacts

Public ContactXiaowen Pu

Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine

puxiaowen@51mch.com+86 13564941413

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026